Are Accurins the cure for Aurora kinase inhibitors?

    loading  Checking for direct PDF access through Ovid

Abstract

A nanoparticle formulation of an Aurora B inhibitor increases antitumor efficacy and reduces toxicity, which may be a precedent for the use of this technology with other small molecules (Ashton et al., this issue).

Related Topics

    loading  Loading Related Articles